[ Price : $8.95]
Healthcare advocacy organizations call on key House lawmakers to hold hearings and advance bipartisan legislation aimed at lowerin...[ Price : $8.95]
FDA agrees to hear an Outlook Therapeutics formal dispute resolution request regarding the agencys prior rejection of eye disease ...[ Price : $8.95]
A federal judge declines to immediately restrict access to the abortion pill mifepristone, instead pausing a high-profile lawsuit ...[ Price : $8.95]
Three stakeholders express support for FDAs LEADER 3D rare disease educational materials and suggest ways to improve them.[ Price : $8.95]
Amgen reports positive topline results from a Phase 3 trial evaluating a subcutaneous version of its thyroid eye disease drug Tepe...[ Price : $8.95]
ImmunityBio says it has responded to FDAs recent Warning Letter on the companys alleged misleading promotional claims about its ca...[ Price : $8.95]
FDA clears an Anumana 510(k) for an artificial intelligencebased tool designed to detect early signs of pulmonary hypertension.[ Price : $8.95]
FDA posts a Form 483 that identifies deficiencies in quality system procedures at a manufacturing facility operated by CSL Behring...